Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study

Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A... Cardiovasc Intervent Radiol (2017) 40:1440–1446 DOI 10.1007/s00270-017-1662-9 CLINICAL INVESTIGATION NON-VASCULAR INTERVENTIONS Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study 1 2 2 3 • • • • Gianluigi Patelli Antonio Ranieri Aurelio Paganelli Giovanni Mauri Claudio Maurizio Pacella Received: 18 December 2016 / Accepted: 21 April 2017 / Published online: 4 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract 10,522 ± 3290.5 J, mean hospital stay 1.5 ± 0.4 days, and Purpose To assess the feasibility and safety of transper- mean catheterization time 17.3 ± 10.0 days. At 3 months, ineal laser ablation (TPLA) for treating benign prostatic IPSS improved from 21.9 to 10.7 (P\ 0.001), QoL from hyperplasia (BPH). 4.7 ± 0.6 to 2.1 ± 1.2 (P\ 0.001), Q from 7.6 to 13.3 max Materials and Methods Institutional review board approval mL/s (P = 0.001), PVR from 199.9 ± 147.3to81.5 ± 97.8 was obtained for this prospective non-randomized trial. (P\ 0.001), and mean prostate volume from 69.8 to 54.8 mL Eightteen patients (age 71.7 ± 9.4 years) with urinary (P\ 0.001). symptoms secondary to BPH underwent TPLA under local Conclusions TPLA is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png CardioVascular and Interventional Radiology Springer Journals

Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study

Loading next page...
 
/lp/springer_journal/transperineal-laser-ablation-for-percutaneous-treatment-of-benign-qsF2xT4WbX
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
Subject
Medicine & Public Health; Imaging / Radiology; Cardiology; Nuclear Medicine; Ultrasound
ISSN
0174-1551
eISSN
1432-086X
D.O.I.
10.1007/s00270-017-1662-9
Publisher site
See Article on Publisher Site

Abstract

Cardiovasc Intervent Radiol (2017) 40:1440–1446 DOI 10.1007/s00270-017-1662-9 CLINICAL INVESTIGATION NON-VASCULAR INTERVENTIONS Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study 1 2 2 3 • • • • Gianluigi Patelli Antonio Ranieri Aurelio Paganelli Giovanni Mauri Claudio Maurizio Pacella Received: 18 December 2016 / Accepted: 21 April 2017 / Published online: 4 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract 10,522 ± 3290.5 J, mean hospital stay 1.5 ± 0.4 days, and Purpose To assess the feasibility and safety of transper- mean catheterization time 17.3 ± 10.0 days. At 3 months, ineal laser ablation (TPLA) for treating benign prostatic IPSS improved from 21.9 to 10.7 (P\ 0.001), QoL from hyperplasia (BPH). 4.7 ± 0.6 to 2.1 ± 1.2 (P\ 0.001), Q from 7.6 to 13.3 max Materials and Methods Institutional review board approval mL/s (P = 0.001), PVR from 199.9 ± 147.3to81.5 ± 97.8 was obtained for this prospective non-randomized trial. (P\ 0.001), and mean prostate volume from 69.8 to 54.8 mL Eightteen patients (age 71.7 ± 9.4 years) with urinary (P\ 0.001). symptoms secondary to BPH underwent TPLA under local Conclusions TPLA is

Journal

CardioVascular and Interventional RadiologySpringer Journals

Published: May 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off